Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Cpn10 add-on trial in rheumatoid arthritis on methotrexate
ACTRN12608000208303Phase 2Active, not recruiting
- Sponsor
- Cbio
- Start
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 2 trial of ala-cpn10 in rheumatoid arthritis (RA) (3 arms), sponsored by Cbio. Primary endpoint: ACR20 response rate. Started May 2008; status: active, not recruiting.
02
Drugs
ala-cpn10
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ACTRN12608000208303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000208303.